Literature DB >> 24460393

Target gene knockdown by 2',4'-BNA/LNA antisense oligonucleotides in zebrafish.

Motoyuki Itoh1, Mizuki Nakaura, Takeshi Imanishi, Satoshi Obika.   

Abstract

Gene knockdowns using oligonucleotide-based approaches are useful for studying gene function in both in vitro cell culture systems and in vivo animal models. We evaluated the efficacy of 2',4'-bridged nucleic acids (BNA)-modified antisense oligonucleotides (AONs) for gene knockdown in zebrafish. We used the tcf7l1a gene as a model for testing the knockdown efficacy of 2',4'-BNA AONs and examined how the target sites/affinity and RNase H induction activity of 2',4'-BNA AONs affect knockdown efficacy. We found that tcf7l1a gene function was knocked down by 2',4'-BNA AONs that target the start codon and induce RNase H activity. Although nonspecific p53-mediated developmental defects were observed at higher doses, the effective dose of the 2',4'-BNA AONs for tcf7l1a is much lower than that of morpholino oligonucleotides. Our data thus show a potential application for 2',4'-BNA AONs in the downregulation of specific genes in zebrafish.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24460393     DOI: 10.1089/nat.2013.0464

Source DB:  PubMed          Journal:  Nucleic Acid Ther        ISSN: 2159-3337            Impact factor:   5.486


  5 in total

1.  Nanoparticle-mediated siRNA Gene-silencing in Adult Zebrafish Heart.

Authors:  Chenglu Xiao; Fang Wang; Junjie Hou; Xiaojun Zhu; Ying Luo; Jing-Wei Xiong
Journal:  J Vis Exp       Date:  2018-07-29       Impact factor: 1.355

2.  Mindbomb 2 is dispensable for embryonic development and Notch signalling in zebrafish.

Authors:  Shohei Mikami; Mizuki Nakaura; Atsuo Kawahara; Takamasa Mizoguchi; Motoyuki Itoh
Journal:  Biol Open       Date:  2015-10-30       Impact factor: 2.422

3.  Enhanced Delivery of Therapeutic siRNA into Glioblastoma Cells Using Dendrimer-Entrapped Gold Nanoparticles Conjugated with β-Cyclodextrin.

Authors:  Jieru Qiu; Lingdan Kong; Xueyan Cao; Aijun Li; Ping Wei; Lu Wang; Serge Mignani; Anne-Marie Caminade; Jean-Pierre Majoral; Xiangyang Shi
Journal:  Nanomaterials (Basel)       Date:  2018-02-27       Impact factor: 5.076

Review 4.  Mutation-Directed Therapeutics for Neurofibromatosis Type I.

Authors:  Andre Leier; David M Bedwell; Ann T Chen; George Dickson; Kim M Keeling; Robert A Kesterson; Bruce R Korf; Tatiana T Marquez Lago; Ulrich F Müller; Linda Popplewell; Jiangbing Zhou; Deeann Wallis
Journal:  Mol Ther Nucleic Acids       Date:  2020-04-29       Impact factor: 8.886

5.  Antisense oligonucleotide gapmers containing phosphoryl guanidine groups reverse MDR1-mediated multiple drug resistance of tumor cells.

Authors:  Maxim S Kupryushkin; Anton V Filatov; Nadezhda L Mironova; Olga A Patutina; Ivan V Chernikov; Elena L Chernolovskaya; Marina A Zenkova; Dmitrii V Pyshnyi; Dmitry A Stetsenko; Sidney Altman; Valentin V Vlassov
Journal:  Mol Ther Nucleic Acids       Date:  2021-11-29       Impact factor: 8.886

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.